Slc9a3tm3.1Niba
Targeted Allele Detail
|
|
| Symbol: |
Slc9a3tm3.1Niba |
| Name: |
solute carrier family 9 (sodium/hydrogen exchanger), member 3; targeted mutation 3.1, Nick Barker |
| MGI ID: |
MGI:6450740 |
| Synonyms: |
Slc9a3-2A-EGFP |
| Gene: |
Slc9a3 Location: Chr13:74269576-74317561 bp, + strand Genetic Position: Chr13, 40.15 cM
|
| Alliance: |
Slc9a3tm3.1Niba page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:292580
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
Not Specified
|
|
| Allele Type: |
|
Targeted (Reporter) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: Sequence for the 2A self-cleaving peptide, the EGFP fluorescent marker gene and a loxP site flanked neomycin resistance gene cassette were inserted immediately before the stop codon. The neo cassette was removed through subsequent cre-mediated recombination. This allele expresses the endogenous peptide and the inserted EGFR peptide.
(J:292580)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Slc9a3 Mutation: |
45 strains or lines available
|
|
| Original: |
J:292580 Tan SH, et al., AQP5 enriches for stem cells and cancer origins in the distal stomach. Nature. 2020 Feb;578(7795):437-443 |
| All: |
1 reference(s) |
|